The Manufacturers Life Insurance Company Buys Shares of 107,320 Envista Holdings Corporation $NVST

The Manufacturers Life Insurance Company bought a new stake in Envista Holdings Corporation (NYSE:NVST) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 107,320 shares of the company’s stock, valued at approximately $2,828,000. The Manufacturers Life Insurance Company owned approximately 0.07% of Envista as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of NVST. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in Envista during the second quarter valued at $25,000. Caitong International Asset Management Co. Ltd boosted its position in Envista by 16,711.1% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock worth $31,000 after acquiring an additional 1,504 shares during the period. Allworth Financial LP grew its stake in Envista by 75.4% during the 4th quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock valued at $39,000 after acquiring an additional 776 shares in the last quarter. UMB Bank n.a. grew its stake in Envista by 46.1% during the 4th quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock valued at $44,000 after acquiring an additional 636 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Envista by 73.1% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock valued at $44,000 after purchasing an additional 949 shares during the period.

Analyst Ratings Changes

A number of analysts have recently issued reports on the stock. Wall Street Zen raised shares of Envista from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 22nd. Evercore reiterated an “outperform” rating and issued a $33.00 price objective on shares of Envista in a research note on Thursday, May 7th. Zacks Research upgraded shares of Envista from a “hold” rating to a “strong-buy” rating in a research report on Friday, August 7th. Weiss Ratings raised shares of Envista from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, August 6th. Finally, Morgan Stanley set a $23.00 price target on shares of Envista in a report on Thursday, August 6th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $29.31.

Envista Trading Down 1.8%

Shares of NYSE NVST opened at $26.66 on Wednesday. The business has a 50 day simple moving average of $27.18 and a 200 day simple moving average of $26.31. Envista Holdings Corporation has a 52 week low of $18.77 and a 52 week high of $30.42. The stock has a market cap of $4.28 billion, a price-to-earnings ratio of 45.97, a PEG ratio of 1.29 and a beta of 0.86. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.07 and a current ratio of 2.43.

Envista (NYSE:NVST) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.34 by $0.07. The firm had revenue of $730.50 million for the quarter, compared to analyst estimates of $716.11 million. Envista had a net margin of 3.33% and a return on equity of 7.88%. The company’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same quarter last year, the firm earned $0.26 earnings per share. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. On average, research analysts predict that Envista Holdings Corporation will post 1.53 earnings per share for the current fiscal year.

Insider Transactions at Envista

In related news, SVP Mischa Reis sold 8,000 shares of the business’s stock in a transaction dated Thursday, August 20th. The stock was sold at an average price of $27.50, for a total transaction of $220,000.00. Following the transaction, the senior vice president directly owned 27,321 shares in the company, valued at $751,327.50. The trade was a 22.65% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.99% of the stock is owned by corporate insiders.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.